INSIGHTS ON DRUG DEVELOPMENT
-
Bringing Novel ADC Formats Into The Clinic: AOC Process Development
Antibody-oligonucleotide conjugates introduce conjugation and purification challenges that standard ADC process development wasn't designed to solve. This white paper details practical approaches for each.
-
Why Emerging Drug Developers Can't Afford To Delay Analytical Development
Rushing early pharma development by neglecting quality and analytical frameworks risks regulatory failures, clinical holds, and expensive rework.
-
ADC Development Grows More Complex — SPR Insights Bring Clarity
Explore how real-time kinetic analysis reveals how conjugation, linker chemistry, and drug loading influence antibody–antigen interactions, while enabling sensitive detection of anti-drug antibodies.
-
Peptones And Vaccines: A Synergistic Approach To Enhanced Production And Efficiency
Enhance your vaccine manufacturing with peptones. Explore their benefits, analyze data-driven productivity gains, and learn integration strategies in this informative, on-demand session.
-
How L-Leucine Shapes Spray-Dried Particles6/17/2026
Optimizing L-Leucine balances porosity and surface enrichment in spray-dried formulations. Precise adjustments alter particle structure to enhance aerodynamic performance and lung deposition.
-
This Is Where Quality Starts3/20/2026
Quality takes shape long before a workcell ships. Meet the people and processes that ensure consistent performance through every stage of development, and explore how to build reliability into each step.
-
IP Considerations In Drug Development For Biotech Companies4/20/2026
Integrate a strategic intellectual property approach early in drug development to streamline research, uncover opportunities, and maximize the return on your investment.
-
How Does Cambrex Approach Peptide Development?7/23/2026
Adrian Amador, Director of Chemistry at Snapdragon Chemistry, on rethinking peptide development from the ground up and how liquid-phase processes are delivering efficiency gains.
-
Using DSC And MDSC To Study Material Interactions Of APIs And Excipients1/7/2026
Thermal analysis reveals how particle size and morphology influence material interactions and stability. Learn how DSC and MDSC techniques uncover compatibility issues and guide better excipient selection.
DRUG DEVELOPMENT SOLUTIONS
-
SimpleStep ELISA® kits are sandwich ELISA assays that we have developed to be as simple and effective as possible. Unlike traditional sandwich ELISAs, which take more than three hours to run, SimpleStep ELISA kits generate data in just 90 minutes without compromising performance, using only one wash step and recombinant antibodies for exceptional specificity.
-
Waters has a complete portfolio of liquid chromatography and LC-MS solutions to provide you with accurate data to answer your lab's most pressing questions.
-
Flow cytometry is a powerful and versatile technique to analyze the physical and chemical characteristics of cells or particles.
-
Gain human-relevant insights with patient-derived assay-ready organoids.
-
Our collaborative approach, proven track record, and deep technical expertise enable us to efficiently advance promising candidates, reduce development risk, and help transform innovative ideas into successful therapeutic realities.